Cohort of Patients With Chronic Myelomonocytic Leukemia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorGustave Roussy, Cancer Campus, Grand Paris
About this trial
A prospective, non-interventional study involving the collection of biological samples with associated anonymised data.
Biological samples will be collected at the time of diagnosis and/or as the disease progresses, with or without treatment, always in conjunction with tests scheduled as part of routine care or within the context of a clinical trial.
Eligibility criteria
Qualifiers
Adults aged 18 years and over
Blood monocytosis ≥ 0.5 × 10⁹/L and ≥ 10% of total white blood cells or
Confirmed diagnosis of chronic myelomonocytic leukemia
Regardless of stage (chronic or transformed), and whether or not currently being treated
Disqualifiers
Active, uncontrolled infection (particularly hepatitis B, hepatitis C, HIV)
Refusal informed consent
Trial design
Treatments tested in this trial
- Sampling
Treatment groups
5,000 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov